TABLE 1.

Recipient characteristics

Case number	Age/Gender	Type of transplant	Primary disease for end‐stage kidney disease	Positive donor SARS‐CoV‐2NP swab immediately prior to transplant	SARS‐CoV‐2NP swab follow‐up after transplant	Follow‐up period (days)	Prior recipient vaccination	Induction immunosuppression	Graft outcome at last follow‐up	Upper respiratory like symptoms at follow‐up
1	33/Female	Kidney	Lupus nephritis	Yes	Negative/9 days after transplant	84	No	Thymoglobulin/basiliximab/methylprednisolon	Cr 0.8 mg/dl BUN 17 mg/dl	None
2	21/Female	Kidney	Bilateral renal hypoplasia	Yes	Negative/9 days after transplant	84	1 Week prior to transplant (first dose‐Pfizer)	Thymoglobulin/basiliximab/methylprednisolon	Cr 0.69 mg/dl BUN 6 mg/dl	None
3	50/Female	Kidney	Atrophic kidneys	No	Negative/7 days after transplant	58	No	Thymoglobulin/basiliximab/methylprednisolon	Cr 0.8 mg/dl BUN 13 mg/dl	None
4	22/Male	Liver	Autoimmune hepatitis	No	Negative/13 days after transplant	35	Yes (two doses‐Pfizer)	Methylprednisolone/antithymocyte/rituximab	Normal liver function test	None

Abbreviations: BUN, blood urea nitrogen; Cr, creatinine; NP, nasopharyngeal; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.